Google DeepMind's Isomorphic Labs is preparing for human trials of AI-designed drugs, marking a significant advancement in ...

After years of development, Isomorphic Labs says its AI-created drugs are nearly ready for human trials. Isomorphic Labs, the ...

Google DeepMind's drug discovery company, Isomorphic Labs, is gearing up to launch the human trials of its AI-designed drugs.

这些交易是Isomorphic构建「世界级药物设计引擎」计划的一部分——一个将机器学习研究人员与制药业资深人士结合的系统，旨在更快、更便宜、更高成功率地设计新药。

• Alphabet旗下Isomorphic Labs的总裁科林·默多克（Colin Murdoch）向《财富》杂志透露，该实验室正准备启动人工智能设计药物的人体试验。这家源自DeepMind ...

Google DeepMind's Isomorphic Labs is set to begin human trials of drugs designed by artificial intelligence, marking a ...

刚刚，AI制药从理论迈向实践的关键一步！DeepMind分拆公司，亮出「秘密武器」：基于AlphaFold系统研发的候选药物，已进入人体临床实验。这意味着将大幅缩短新药研发周期、降低成本，加速新药惠及患者。

The researchers argue that CoT monitoring can help researchers detect when models begin to exploit flaws in their training, ...

Isomorphic Labs is preparing to test AI-designed drugs in humans, marking a new phase in drug development with artificial ...

Alphabet’s Isomorphic Labs is preparing to begin human trials of a drug designed using AI, based on protein modelling ...

A secretive, Google-backed lab is using artificial intelligence to invent new medicines for humanity's worst illnesses. But ...

Alphabet’s Isomorphic Labs, spun out of DeepMind, is preparing to start human trials of AI-designed drugs after raising $600 ...